Sichuan Huiyu Pharmaceutical Co., Ltd. (688553.SS) SHH
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Sichuan Huiyu Pharmaceutical Co., Ltd.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1366
First IPO Date
October 26, 2021
Key Executives
| Name | Title | Pay | Year Born |
| He Ping Hu | Director of the Institute of Chemical Drugs of Huiyu Pharmaceutical Research Institute | 0 | 1977 |
| Tao Wei | Director of Institute of Innovative Biopharmaceuticals at Huiyu Pharmaceutical Research Institute | 0 | 1962 |
| Yong Chun Ren | Employee Representative Director & Deputy General Manager | 0 | 1968 |
| Yan Mei Yu | Accounting Supervisor | 0 | N/A |
| Zhao Ding | Chairman of the Board & GM | 0 | 1985 |
| Chun Ping Zhang | Deputy GM, Secretary of the Board & Director | 0 | 1980 |
| Lan Gao | Director & Finance Director | 0 | 1971 |
| Gang Cai | Manager of Technical Department, Quality Manager & Quality Director | 0 | 1977 |
Description
Sichuan Huiyu Pharmaceutical Co., Ltd. researches, develops, produces, and sells anti-tumor injection in China and internationally. It offers injection drug products, such as pemetrexed disodium, methrotrexate, docetaxel, azacitidine, oxaliplatin, cyclophosphamide, irinotecan hydrochloride, paclitaxel, bendamustine hydrochloride, decitabine, palonosetron hydrochloride, plerixafor, levetiracetam concentrated solution, amifostine, levofolate calcium, thiotepa, fulvestrant, and milrinone drugs. The company also offers moroxydine sodium chloride, fluorouracil, sodium thiosulfate, acetylcysteine, nimodipine, nimodipine, dihydroxypropyltheophylline, cisatracurium besylate, cladribine, sodium carbosulfan, octreotide acetate, mesobamo, doxorubicin, leucovorin calcium, famotidine, etoposide, polymyxin B sulfate, melphalan hydrochloride, teicoplanin, epirubicin hydrochloride, gemcitabine hydrochloride, cytarabine, voriconazole, roxatidine acetate hydrochloride, and bortezomib drugs. Sichuan Huiyu Pharmaceutical Co., Ltd. was incorporated in 2010 and is headquartered in Neijiang, China.
